Why follow-back studies should be interpreted cautiously: The case of an HPV-negative cervical lesion.

Giorgi Rossi P, Ronco G, Dillner J, Elfström KM, Snijders PJ, Arbyn M, Berkhof J, Carozzi F, Del Mistro A, De Sanjosè S, Bosch X, Petry KU, Poljak M, Naldoni C, Meijer CJ; Comparing Health Services Interventions for the Prevention of HPV-Related Cancer Consortium and the New Technologies for Cervical Cancer Group.

Cancer Cytopathol 2016; 124: 66-7. (IF 3.092)

http://www.ncbi.nlm.nih.gov/pubmed/26356132